Page last updated: 2024-08-21

dihydroergotamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

dihydroergotamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Etienne, N; Guesnier, L; Hickel, P; Maroteaux, L; Schaerlinger, B1

Other Studies

1 other study(ies) available for dihydroergotamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

ArticleYear
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
    British journal of pharmacology, 2003, Volume: 140, Issue:2

    Topics: Amphetamines; Animals; Binding, Competitive; Cell Line; Cyclic GMP; Dihydroergotamine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Migraine Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Treatment Outcome

2003